CPH 0.00% 0.9¢ creso pharma limited

Ann: Notice of Breach of ASX Listing Rule 10.11, page-16

  1. 928 Posts.
    lightbulb Created with Sketch. 152
    ^^^ ps
    If you look at the lead authors credentials you will see he is fully committed to developing Psilocybin for medicinal use - being deeply involved in the largest, most scientifically credible trials that have yet been done
    - and hence is fully qualified to lay out the massive task CPH has in front of it.

    Don't trouble yourself to think this right thru... at yr peril.
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.